GF Fund Management
MRVI icon

GF Fund Management’s Maravai LifeSciences MRVI Stock Holding History

GF Fund Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25.9K Buy
3,376
+277
+9% +$1.92K ﹤0.01% 467
2026
Q2 		$19.3K Sell
3,099
-142
-4% -$613 ﹤0.01% 489
2026
Q1 		$9.17K Buy
3,241
+392
+14% +$1.33K ﹤0.01% 566
2025
Q4 		$9.26K Sell
2,849
-264
-8% -$889 ﹤0.01% 581
2025
Q3 		$8.93K Sell
3,113
-518
-14% -$1.32K ﹤0.01% 562
2025
Q2 		$8.75K Hold
3,631
– – ﹤0.01% 583
2025
Q1 		$8.02K Buy
3,631
+653
+22% +$2.58K ﹤0.01% 586
2024
Q4 		$16.2K Buy
+2,978
New +$19.2K ﹤0.01% 490

Other funds holding MRVI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
General American Investors
General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return
Hillsdale Investment Management
Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

GF Fund Management's MRVI Position: Q3 2026 in Review

GF Fund Management increased its Maravai LifeSciences (MRVI) stake by 8.9% in Q3 2026, buying an estimated $1.92K and bringing the position to 3,376 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #467.

GF Fund Management first reported a position in MRVI in Q4 2024 and has held it in 8 quarters since. 105 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

  • GF Fund Management held 3,376 shares of Maravai LifeSciences worth $25.9K as of Q3 2026.
  • GF Fund Management bought 277 Maravai LifeSciences shares in Q3 2026, an estimated $1.92K.
  • Maravai LifeSciences made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #467 holding.
  • GF Fund Management first reported a position in Maravai LifeSciences in Q4 2024 and has held it in 8 quarters since.
  • 105 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.